Scholar Rock Holding Corp. (SRRK)
46.82
+1.77
(+3.93%)
USD |
NASDAQ |
Dec 11, 16:00
46.82
0.00 (0.00%)
After-Hours: 20:00
Scholar Rock Research and Development Expense (TTM): 210.30M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 5.097B |
| Lifeward Ltd. | 3.537M |
| Mersana Therapeutics, Inc. | 68.92M |
| Twist Bioscience Corp. | 80.28M |
| ETHZilla Corp. | -- |